Changes in Adenosine 5′-Monophosphate-Activated Protein Kinase as a Mechanism of Visceral Obesity in Cushing’s Syndrome

OBJECTIVE: Features of the metabolic syndrome such as central obesity with insulin resistance and dyslipidemia are typical signs of Cushing’s syndrome and common side effects of prolonged glucocorticoid treatment. AMP-activated protein kinase (AMPK), a key regulatory enzyme of lipid and carbohydrate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Endocrinol Metab
Main Authors: Kola, Blerina, Christ-Crain, Mirjam, Lolli, Francesca, Arnaldi, Giorgio, Giacchetti, Gilberta, Boscaro, Marco, Grossman, Ashley B., Korbonits, Márta
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7611639/
https://ncbi.nlm.nih.gov/pubmed/18782871
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2008-1297
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados